Negative perception of schizophrenia is still prevalent in society. However, schizophrenia is only a mental disease that ...

A University of Arkansas for Medical Sciences outpatient clinic in Fayetteville is looking to help patients with ...

Myelin loss is common in disorders like multiple sclerosis and schizophrenia, and this research shows that hnRNP A1 disruptions can impair myelination at the molecular level, even before behavioral ...

The research, published in Proceedings of the National Academy of Sciences, highlights the new drug’s potential as a treatment option for conditions like schizophrenia, where psychedelics are not ...

Scientific literature has shown that patients with multiple sclerosis and schizophrenia lose myelin (called demyelination), leaving part of the axons "unplugged" and causing damage to brain function.

However, a review of 43 articles found that, “no single hallucination feature or characteristic uniquely indicated a diagnosis of schizophrenia, with the sole exception of an age of onset in ...

Clinical symptom severity was assessed using the Auditory Hallucination Rating Scale (AHRS). Results: At baseline, schizophrenia patients exhibited disrupted small-world properties, with significantly ...

new research has reinforced the potential of avatar-based therapy to ease auditory hallucinations — one of the most persistent and distressing symptoms in schizophrenia spectrum disorders (SSDs).

Get Instant Summarized Text (Gist) A new drug, JRT, derived from LSD, shows promise for treating schizophrenia by promoting neuroplasticity without causing hallucinations. By altering two atoms in ...

Schizophrenia is a mental illness that affects how you think and behave. The symptoms of schizophrenia include: Schizoid personality disorder. A person with schizoid personality disorder avoids ...